Connection
Larry Allen to Aged
This is a "connection" page, showing publications Larry Allen has written about Aged.
|
|
Connection Strength |
|
|
|
|
|
2.349 |
|
|
|
-
McIlvennan CK, Jones J, Makic M, Meek PM, Chaussee E, Thompson JS, Matlock DD, Allen LA. Stress and Coping Among Family Caregivers of Patients With a Destination Therapy Left Ventricular Assist Device: A Multicenter Mixed Methods Study. Circ Heart Fail. 2021 10; 14(10):e008243.
Score: 0.055
-
Gottlieb SS, Psotka MA, Desai N, Lindenfeld J, Russo P, Allen LA. Use of Outpatient Intravenous Calcitropes for Heart Failure in the United States. J Card Fail. 2021 11; 27(11):1276-1279.
Score: 0.054
-
Dickert NW, Mitchell AR, Venechuk GE, Matlock DD, Moore MA, Morris AA, Pierce KJ, Speight CD, Allen LA. Show Me the Money: Patients' Perspectives on a Decision Aid for Sacubitril/Valsartan Addressing Out-of-Pocket Cost. Circ Cardiovasc Qual Outcomes. 2020 12; 13(12):e007070.
Score: 0.052
-
Allen LA, Venechuk G, McIlvennan CK, Page RL, Knoepke CE, Helmkamp LJ, Khazanie P, Peterson PN, Pierce K, Harger G, Thompson JS, Dow TJ, Richards L, Huang J, Strader JR, Trinkley KE, Kao DP, Magid DJ, Buttrick PM, Matlock DD. An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF Trial. Circulation. 2021 02 02; 143(5):427-437.
Score: 0.052
-
Fendler TJ, McIlvennan CK, Matlock DD, Thompson JS, Chaussee EL, Dunlay SM, LaRue SJ, Raymer DS, Spertus JA, Lewis EF, Patel CB, Walsh MN, Allen LA. Exploring differences between patients who accept, decline, and are deemed ineligible for left ventricular assist device implantation as destination therapy. J Heart Lung Transplant. 2020 07; 39(7):721-724.
Score: 0.050
-
Matlock DD, McIlvennan CK, Thompson JS, Morris MA, Venechuk G, Dunlay SM, LaRue SJ, Lewis EF, Patel CB, Blue L, Chaussee EL, Glasgow RE, Walsh MN, Allen LA. Decision Aid Implementation among Left Ventricular Assist Device Programs Participating in the DECIDE-LVAD Stepped-Wedge Trial. Med Decis Making. 2020 04; 40(3):289-301.
Score: 0.050
-
Allen LA. How Should Physicians Respond to Requests for LVAD Removal? AMA J Ethics. 2019 05 01; 21(5):E394-400.
Score: 0.047
-
Warraich HJ, Xu H, DeVore AD, Matsouaka R, Heidenreich PA, Bhatt DL, Hernandez AF, Yancy CW, Fonarow GC, Allen LA. Trends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines-Heart Failure Registry. JAMA Cardiol. 2018 10 01; 3(10):917-926.
Score: 0.045
-
Allen LA, Tang F, Jones P, Breeding T, Ponirakis A, Turner SJ. Signs, symptoms, and treatment patterns across serial ambulatory cardiology visits in patients with heart failure: insights from the NCDR PINNACLE? registry. BMC Cardiovasc Disord. 2018 05 03; 18(1):80.
Score: 0.043
-
Allen LA, McIlvennan CK, Thompson JS, Dunlay SM, LaRue SJ, Lewis EF, Patel CB, Blue L, Fairclough DL, Leister EC, Glasgow RE, Cleveland JC, Phillips C, Baldridge V, Walsh MN, Matlock DD. Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device: The DECIDE-LVAD Randomized Clinical Trial. JAMA Intern Med. 2018 04 01; 178(4):520-529.
Score: 0.043
-
Mathew JS, Marzec LN, Kennedy KF, Jones PG, Varosy PD, Masoudi FA, Maddox TM, Allen LA. Atrial Fibrillation in Heart Failure US Ambulatory Cardiology Practices and the Potential for Uptake of Catheter Ablation: An National Cardiovascular Data Registry (NCDR?) Research to Practice (R2P) Project. J Am Heart Assoc. 2017 Aug 11; 6(8).
Score: 0.041
-
Allen LA, Matlock DD, Shetterly SM, Xu S, Levy WC, Portalupi LB, McIlvennan CK, Gurwitz JH, Johnson ES, Smith DH, Magid DJ. Use of Risk Models to Predict Death in the Next Year Among Individual Ambulatory Patients With Heart Failure. JAMA Cardiol. 2017 04 01; 2(4):435-441.
Score: 0.040
-
Flint KM, Spertus JA, Tang F, Jones P, Fendler TJ, Allen LA. Association of global and disease-specific health status with outcomes following continuous-flow left ventricular assist device implantation. BMC Cardiovasc Disord. 2017 03 14; 17(1):78.
Score: 0.040
-
Thompson JS, Matlock DD, McIlvennan CK, Jenkins AR, Allen LA. Development of a Decision Aid for Patients?With Advanced Heart Failure Considering a Destination Therapy Left?Ventricular Assist Device. JACC Heart Fail. 2015 Dec; 3(12):965-76.
Score: 0.037
-
Allen LA, Fonarow GC, Liang L, Schulte PJ, Masoudi FA, Rumsfeld JS, Ho PM, Eapen ZJ, Hernandez AF, Heidenreich PA, Bhatt DL, Peterson ED, Krumholz HM. Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures. Circulation. 2015 Oct 06; 132(14):1347-53.
Score: 0.036
-
Allen LA, Fonarow GC, Simon DN, Thomas LE, Marzec LN, Pokorney SD, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Chang P, Peterson ED, Piccini JP. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort. J Am Coll Cardiol. 2015 Jun 30; 65(25):2691-8.
Score: 0.036
-
Allen LA, Yood MU, Wagner EH, Aiello Bowles EJ, Pardee R, Wellman R, Habel L, Nekhlyudov L, Davis RL, Onitilo AA, Magid DJ. Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Med Care. 2014 May; 52(5):e30-8.
Score: 0.033
-
Allen LA, Fonarow GC, Grau-Sepulveda MV, Hernandez AF, Peterson PN, Partovian C, Li SX, Heidenreich PA, Heidenrich PA, Bhatt DL, Peterson ED, Krumholz HM. Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines. Circ Heart Fail. 2014 Mar 01; 7(2):251-60.
Score: 0.032
-
Allen LA, Shetterly SM, Peterson PN, Gurwitz JH, Smith DH, Brand DW, Fairclough DL, Rumsfeld JS, Masoudi FA, Magid DJ. Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure. Circ Heart Fail. 2014 Jan; 7(1):43-50.
Score: 0.032
-
Flint KM, Matlock DD, Sundareswaran KS, Lindenfeld J, Spertus JA, Farrar DJ, Allen LA. Pre-operative health status and outcomes after continuous-flow left ventricular assist device implantation. J Heart Lung Transplant. 2013 Dec; 32(12):1249-54.
Score: 0.032
-
Allen LA, Magid DJ, Gurwitz JH, Smith DH, Goldberg RJ, Saczynski J, Thorp ML, Hsu G, Sung SH, Go AS. Risk factors for adverse outcomes by left ventricular ejection fraction in a contemporary heart failure population. Circ Heart Fail. 2013 Jul; 6(4):635-46.
Score: 0.031
-
Retrum JH, Boggs J, Hersh A, Wright L, Main DS, Magid DJ, Allen LA. Patient-identified factors related to heart failure readmissions. Circ Cardiovasc Qual Outcomes. 2013 Mar 01; 6(2):171-7.
Score: 0.030
-
Vigen R, Maddox TM, Allen LA. Aging of the United States population: impact on heart failure. Curr Heart Fail Rep. 2012 Dec; 9(4):369-74.
Score: 0.030
-
Allen LA, Smoyer Tomic KE, Wilson KL, Smith DM, Agodoa I. The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type. J Med Econ. 2013; 16(1):43-54.
Score: 0.029
-
Allen LA, Magid DJ, Zeng C, Peterson PN, Clarke CL, Shetterly S, Brand DW, Masoudi FA. Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization. BMC Cardiovasc Disord. 2012 Jun 18; 12:43.
Score: 0.029
-
Allen LA, Gheorghiade M, Reid KJ, Dunlay SM, Chan PS, Hauptman PJ, Zannad F, Konstam MA, Spertus JA. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes. 2011 Jul; 4(4):389-98.
Score: 0.027
-
Allen LA, Hernandez AF, Peterson ED, Curtis LH, Dai D, Masoudi FA, Bhatt DL, Heidenreich PA, Fonarow GC. Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ Heart Fail. 2011 May; 4(3):293-300.
Score: 0.027
-
Allen LA, Turer AT, Dewald T, Stough WG, Cotter G, O'Connor CM. Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure. Am J Cardiol. 2010 Jun 15; 105(12):1794-7.
Score: 0.025
-
Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK, Lenihan DJ, Oren RM, Wagoner LE, Schwartz TA, Adams KF. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail. 2010 Mar; 16(3):230-8.
Score: 0.024
-
Allen LA, Anstrom KJ, Horton JR, Shaw LK, Eisenstein EL, Felker GM. Relationship between anemia and health care costs in heart failure. J Card Fail. 2009 Dec; 15(10):843-9.
Score: 0.024
-
Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009 Feb; 11(2):170-7.
Score: 0.023
-
Havranek EP, Allen LA. Listening to patients. J Am Coll Cardiol. 2008 Nov 18; 52(21):1709-10.
Score: 0.023
-
Allen LA, Metra M, Milo-Cotter O, Filippatos G, Reisin LH, Bensimhon DR, Gronda EG, Colombo P, Felker GM, Cas LD, Kremastinos DT, O'Connor CM, Cotter G, Davison BA, Dittrich HC, Velazquez EJ. Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of measures of disease severity in acute heart failure (MEASURE-AHF). J Card Fail. 2008 Nov; 14(9):777-84.
Score: 0.022
-
Allen LA, Yager JE, Funk MJ, Levy WC, Tulsky JA, Bowers MT, Dodson GC, O'Connor CM, Felker GM. Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA. 2008 Jun 04; 299(21):2533-42.
Score: 0.022
-
Allen LA, O'Connor CM. Management of acute decompensated heart failure. CMAJ. 2007 Mar 13; 176(6):797-805.
Score: 0.020
-
Allen LA, O'Donnell CJ, Camargo CA, Giugliano RP, Lloyd-Jones DM. Comparison of long-term mortality across the spectrum of acute coronary syndromes. Am Heart J. 2006 May; 151(5):1065-71.
Score: 0.019
-
Allen LA, O'Donnell CJ, Giugliano RP, Camargo CA, Lloyd-Jones DM. Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non-ST-elevation myocardial infarction. Am J Cardiol. 2004 May 15; 93(10):1218-22.
Score: 0.017
-
Oddleifson DA, Holmes DN, Alhanti B, Xu X, Heidenreich PA, Wadhera RK, Allen LA, Greene SJ, Fonarow GC, Spatz ES, Desai NR. Bundled Payments for Care Improvement and Quality of Care and Outcomes in Heart Failure. JAMA Cardiol. 2024 Mar 01; 9(3):222-232.
Score: 0.016
-
Shah KP, Khan SS, Baldridge AS, Grady KL, Cella D, Goyal P, Allen LA, Smith JD, Lagu TC, Ahmad FS. Health Status in Heart?Failure and Cancer: Analysis of the Medicare Health Outcomes Survey 2016-2020. JACC Heart Fail. 2024 Jul; 12(7):1166-1178.
Score: 0.016
-
Keshvani N, Shah S, Ayodele I, Chiswell K, Alhanti B, Allen LA, Greene SJ, Yancy CW, Alonso WW, Van Spall HG, Fonarow GC, Heidenreich PA, Pandey A. Sex differences in long-term outcomes following acute heart failure hospitalization: Findings from the Get With The Guidelines-Heart Failure registry. Eur J Heart Fail. 2023 09; 25(9):1544-1554.
Score: 0.016
-
Pierce JB, Blumer V, Choi S, Hardy NC, Greiner MA, Carnicelli AP, Shen X, Lippmann SJ, Peterson PN, Allen LA, Fonarow GC, Mentz RJ, Greene SJ, O'Brien EC. Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Na?ve to Renin-Angiotensin System Inhibitors. Am J Cardiol. 2023 10 01; 204:151-158.
Score: 0.016
-
Keshvani N, Subramanian V, Wrobel CA, Solomon N, Alhanti B, Greene SJ, DeVore AD, Yancy CW, Allen LA, Fonarow GC, Pandey A. Patterns of Referral and Postdischarge Utilization of Cardiac Rehabilitation Among Patients Hospitalized With Heart Failure: An Analysis From the GWTG-HF Registry. Circ Heart Fail. 2023 08; 16(8):e010144.
Score: 0.016
-
Diamond J, Ayodele I, Fonarow GC, Joynt-Maddox KE, Yeh RW, Hammond G, Allen LA, Greene SJ, Chiswell K, DeVore AD, Yancy C, Wadhera RK. Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults: Get With The Guidelines-Heart Failure Registry. JAMA Cardiol. 2023 06 01; 8(6):545-553.
Score: 0.015
-
Harrington J, Sun JL, Fonarow GC, Heitner SB, Divanji PH, Binder G, Allen LA, Alhanti B, Yancy CW, Albert NM, DeVore AD, Felker GM, Greene SJ. Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction. J Am Heart Assoc. 2023 05 16; 12(10):e028820.
Score: 0.015
-
Mentias A, Peterson ED, Keshvani N, Kumbhani DJ, Yancy CW, Morris AA, Allen LA, Girotra S, Fonarow GC, Starling RC, Alvarez P, Desai MY, Cram P, Pandey A. Achieving Equity in Hospital Performance Assessments Using Composite Race-Specific Measures of Risk-Standardized Readmission and Mortality Rates for Heart Failure. Circulation. 2023 04 11; 147(15):1121-1133.
Score: 0.015
-
Pierce JB, Ikeaba U, Peters AE, DeVore AD, Chiswell K, Allen LA, Albert NM, Yancy CW, Fonarow GC, Greene SJ. Quality of Care and Outcomes Among Patients Hospitalized for Heart Failure in Rural vs Urban US Hospitals: The Get With The Guidelines-Heart Failure Registry. JAMA Cardiol. 2023 04 01; 8(4):376-385.
Score: 0.015
-
Hahn EA, Allen LA, Lee CS, Denfeld QE, Stehlik J, Cella D, Lindenfeld J, Teuteberg JJ, McIlvennan CK, Kiernan MS, Beiser DG, Walsh MN, Adler ED, Ruo B, Kirklin JK, Klein L, Bedjeti K, Cummings PD, Burns JL, Vela AM, Grady KL. PROMIS: Physical, Mental and Social Health Outcomes Improve From Before to Early After LVAD Implant: Findings From the Mechanical Circulatory Support: Measures of Adjustment and Quality of Life (MCS A-QOL) Study. J Card Fail. 2023 10; 29(10):1398-1411.
Score: 0.015
-
Goyal P, Zullo AR, Gladders B, Onyebeke C, Kwak MJ, Allen LA, Levitan EB, Safford MM, Gilstrap L. Real-world safety of neurohormonal antagonist initiation among older adults following a heart failure hospitalization. ESC Heart Fail. 2023 06; 10(3):1623-1634.
Score: 0.015
-
Khan MS, Xu H, Fonarow GC, Lautsch D, Hilkert R, Allen LA, DeVore AD, Alhanti B, Yancy CW, Albert NM, Butler J, Greene SJ. Applicability of Vericiguat to Patients Hospitalized for Heart?Failure in the United States. JACC Heart Fail. 2023 02; 11(2):211-223.
Score: 0.015
-
Selvaraj S, Greene SJ, Ayodele I, Alhanti B, Allen LA, Lewsey SC, Adusumalli S, Reza N, Hernandez AF, Yancy CW, Jena AB, Fonarow GC, Bhatt DL. Assessing Heuristic Bias During Care for Patients Hospitalized for Heart Failure: Get With The Guidelines-Heart Failure. Circ Heart Fail. 2023 02; 16(2):e010069.
Score: 0.015
-
Knoepke CE, Wallace BC, Allen LA, Lewis CL, Gupta SK, Peterson PN, Kramer DB, Brancato SC, Varosy PD, Mandrola JM, Tzou WS, Matlock DD. Experiences Implementing a Suite of Decision Aids for Implantable Cardioverter Defibrillators: Qualitative Insights From the DECIDE-ICD Trial. Circ Cardiovasc Qual Outcomes. 2022 11; 15(11):e009352.
Score: 0.015
-
Hernandez AF, Albert NM, Allen LA, Ahmed R, Averina V, Boehmer JP, Cowie MR, Chien CV, Galvao M, Klein L, Kwan B, Lam CSP, Ruble SB, Stolen CM, Stein K. Multiple cArdiac seNsors for mAnaGEment of Heart Failure (MANAGE-HF) - Phase I Evaluation of the Integration and Safety of the HeartLogic Multisensor Algorithm in Patients With Heart Failure. J Card Fail. 2022 08; 28(8):1245-1254.
Score: 0.014
-
Patel KV, Keshvani N, Pandey A, Vaduganathan M, Holmes DN, Matsouaka RA, DeVore AD, Allen LA, Yancy CW, Fonarow GC. Association of readmission penalty amount with subsequent 30-day risk standardized readmission and mortality rates among patients hospitalized with heart failure: An analysis of get with the guidelines - heart failure participating centers. Am Heart J. 2022 04; 246:1-11.
Score: 0.014
-
Van Spall HGC, DeFilippis EM, Lee SF, Oz UE, Perez R, Healey JS, Allen LA, Voors AA, Ko DT, Thabane L, Connolly SJ. Sex-Specific Clinical Outcomes of the PACT-HF Randomized Trial. Circ Heart Fail. 2021 11; 14(11):e008548.
Score: 0.014
-
Goyal P, Reshetnyak E, Khan S, Musse M, Navi BB, Kim J, Allen LA, Banerjee S, Elkind MSV, Shah SJ, Yancy C, Michos ED, Devereux RB, Okin PM, Weinsaft JW, Safford MM. Clinical Characteristics and Outcomes of Adults With a History of Heart Failure Hospitalized for COVID-19. Circ Heart Fail. 2021 09; 14(9):e008354.
Score: 0.014
-
Carnicelli AP, Li Z, Greiner MA, Lippmann SJ, Greene SJ, Mentz RJ, Hardy NC, Blumer V, Shen X, Yancy CW, Peterson PN, Allen LA, Fonarow GC, O'Brien EC. Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart?Failure With Reduced Ejection Fraction. JACC Heart Fail. 2021 12; 9(12):876-886.
Score: 0.014
-
Carnicelli AP, Lippmann SJ, Greene SJ, Mentz RJ, Greiner MA, Hardy NC, Hammill BG, Shen X, Yancy CW, Peterson PN, Allen LA, Fonarow GC, O'Brien EC. Sacubitril/Valsartan Initiation and Postdischarge Adherence Among Patients Hospitalized for Heart Failure. J Card Fail. 2021 08; 27(8):826-836.
Score: 0.014
-
DeVore AD, Granger BB, Fonarow GC, Al-Khalidi HR, Albert NM, Lewis EF, Butler J, Pi?a IL, Allen LA, Yancy CW, Cooper LB, Felker GM, Kaltenbach LA, McRae AT, Lanfear DE, Harrison RW, Disch M, Ariely D, Miller JM, Granger CB, Hernandez AF. Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial. JAMA. 2021 07 27; 326(4):314-323.
Score: 0.014
-
Bahiru E, Ziaeian B, Moucheraud C, Agarwal A, Xu H, Matsouaka RA, DeVore AD, Heidenreich PA, Allen LA, Yancy CW, Fonarow GC. Association of Dual Eligibility for Medicare and Medicaid With Heart Failure Quality and Outcomes Among Get With The Guidelines-Heart Failure Hospitals. JAMA Cardiol. 2021 07 01; 6(7):791-800.
Score: 0.014
-
Mitchell JE, Chesler R, Zhang S, Matsouaka RA, Devore AD, Allen LA, Albert NM, Fraser M, Yancy CW, Chang NL, Fonarow GC. Profile of Patients Hospitalized for Heart Failure Who Leave Against Medical Advice. J Card Fail. 2021 07; 27(7):747-755.
Score: 0.013
-
Levy AE, Hammes A, Anoff DL, Raines JD, Beck NM, Rudofker EW, Marshall KJ, Nensel JD, Messenger JC, Masoudi FA, Pierce RG, Allen LA, Ream KS, Ho PM. Acute Myocardial Infarction Cohorts Defined by International Classification of Diseases, Tenth Revision Versus Diagnosis-Related Groups: Analysis of Diagnostic Agreement and Quality Measures in an Integrated Health System. Circ Cardiovasc Qual Outcomes. 2021 03; 14(3):e006570.
Score: 0.013
-
Knoepke CE, Allen LA, Sepucha K, Masoudi FA, Kutner J, Varosy P, Magid D, Matlock DD. Development of a measure of decision quality for implantable defibrillators. Pacing Clin Electrophysiol. 2021 04; 44(4):677-684.
Score: 0.013
-
Ali-Ahmed F, Pieper K, North R, Allen LA, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Go AS, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli GV, Pokorney SD, Reiffel JA, Singer DE, Steinberg BA, Peterson ED, Piccini JP, O'Brien EC. Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions. Eur Heart J Qual Care Clin Outcomes. 2020 10 01; 6(4):263-272.
Score: 0.013
-
Sterling MR, Kern LM, Safford MM, Jones CD, Feldman PH, Fonarow GC, Sheng S, Matsouaka RA, DeVore AD, Lytle B, Xu H, Allen LA, Deswal A, Yancy CW, Albert NM. Home Health Care Use and Post-Discharge Outcomes After Heart?Failure Hospitalizations. JACC Heart Fail. 2020 12; 8(12):1038-1049.
Score: 0.013
-
Madhavan M, Holmes DN, Piccini JP, Freeman JV, Fonarow GC, Hylek EM, Kowey PR, Mahaffey KW, Pieper K, Peterson ED, Chan PS, Allen LA, Singer DE, Naccarelli GV, Reiffel JA, Steinberg BA, Gersh BJ. Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF). Am J Cardiol. 2020 10 01; 132:66-71.
Score: 0.013
-
Sherwood MW, Piccini JP, Holmes DN, Pieper KS, Steinberg BA, Fonarow GC, Allen LA, Naccarelli GV, Kowey PR, Gersh BJ, Mahaffey KW, Singer DE, Ansell JE, Freeman JV, Chan PS, Reiffel JA, Blanco R, Peterson ED, Rao SV. Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry. Circ Cardiovasc Interv. 2020 05; 13(5):e008274.
Score: 0.013
-
Steinberg BA, Holmes DN, Pieper K, Allen LA, Chan PS, Ezekowitz MD, Freeman JV, Fonarow GC, Gersh BJ, Hylek EM, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Singer DE, Peterson ED, Piccini JP. Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AF. Circ Arrhythm Electrophysiol. 2020 05; 13(5):e007775.
Score: 0.012
-
McIlvennan CK, Matlock DD, Allen LA, Thompson JS, Ranby KW, Sannes TS. Perceived Stress and Depressive Symptoms as Predictors of Decisional Conflict in Dyads Considering a Left Ventricular Assist Device. Circ Cardiovasc Qual Outcomes. 2020 03; 13(3):e006155.
Score: 0.012
-
Inohara T, Holmes DN, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Hylek EM, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP. Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation. Heart. 2020 03; 106(5):358-364.
Score: 0.012
-
Dalgaard F, North R, Pieper K, Fonarow GC, Kowey PR, Gersh BJ, Mahaffey KW, Pokorney S, Steinberg BA, Naccarrelli G, Allen LA, Reiffel JA, Ezekowitz M, Singer DE, Chan PS, Peterson ED, Piccini JP. Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation. Am Heart J. 2020 05; 223:65-71.
Score: 0.012
-
Tate CE, Venechuk G, Brereton EJ, Ingle P, Allen LA, Morris MA, Matlock DD. "It's Like a Death Sentence but It Really Isn't" What Patients and Families Want to Know About Hospice Care When Making End-of-Life Decisions. Am J Hosp Palliat Care. 2020 Sep; 37(9):721-727.
Score: 0.012
-
Hess PL, Sheng S, Matsouaka R, DeVore AD, Heidenreich PA, Yancy CW, Bhatt DL, Allen LA, Peterson PN, Ho PM, Lewis WR, Hernandez AF, Fonarow GC, Piccini JP. Strict Versus Lenient Versus Poor Rate Control Among Patients With Atrial Fibrillation and Heart Failure (from the Get With The Guidelines - Heart Failure Program). Am J Cardiol. 2020 03 15; 125(6):894-900.
Score: 0.012
-
Freeman JV, Shrader P, Pieper KS, Allen LA, Chan PS, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel JA, Singer DE, Go AS, Hylek EM, Steinberg BA, Peterson ED, Piccini JP. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2019 12; 12(12):e007612.
Score: 0.012
-
Kelly JP, DeVore AD, Wu J, Hammill BG, Sharma A, Cooper LB, Felker GM, Piccini JP, Allen LA, Heidenreich PA, Peterson ED, Yancy CW, Fonarow GC, Hernandez AF. Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines-Heart Failure. J Am Heart Assoc. 2019 12 17; 8(24):e011560.
Score: 0.012
-
Loring Z, Shrader P, Allen LA, Blanco R, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Mahaffey KW, Naccarelli GV, Pieper K, Reiffel JA, Singer DE, Steinberg BA, Thomas LE, Peterson ED, Piccini JP. Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation. Am Heart J. 2020 01; 219:21-30.
Score: 0.012
-
Hadler RA, Goldstein NE, Bekelman DB, Riegel B, Allen LA, Arnold RM, Harinstein ME, Kavalieratos D. "Why Would I Choose Death?": A Qualitative Study of Patient Understanding of the Role and Limitations of Cardiac Devices. J Cardiovasc Nurs. 2019 May/Jun; 34(3):275-282.
Score: 0.012
-
Holmes DN, Piccini JP, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, O'Brien EC, Reiffel JA, Naccarelli GV, Ezekowitz MD, Chan PS, Singer DE, Spertus JA, Peterson ED, Thomas L. Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score. Circ Cardiovasc Qual Outcomes. 2019 05; 12(5):e005358.
Score: 0.012
-
Warraich HJ, Allen LA, Blue LJ, Chaussee EL, Thompson JS, McIlvennan CK, Flint KM, Matlock DD, Patel CB. Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study. Am Heart J. 2019 07; 213:91-96.
Score: 0.012
-
Inohara T, Shrader P, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Go AS, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP. Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II. Am Heart J. 2019 07; 213:81-90.
Score: 0.012
-
Madhavan M, Holmes DN, Piccini JP, Ansell JE, Fonarow GC, Hylek EM, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Chan P, Allen LA, Gersh BJ. Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation. Am Heart J. 2019 05; 211:77-89.
Score: 0.011
-
Smith GH, Shore S, Allen LA, Markham DW, Mitchell AR, Moore M, Morris AA, Speight CD, Dickert NW. Discussing Out-of-Pocket Costs With Patients: Shared Decision Making for Sacubitril-Valsartan in Heart Failure. J Am Heart Assoc. 2019 01 08; 8(1):e010635.
Score: 0.011
-
Essien UR, Holmes DN, Jackson LR, Fonarow GC, Mahaffey KW, Reiffel JA, Steinberg BA, Allen LA, Chan PS, Freeman JV, Blanco RG, Pieper KS, Piccini JP, Peterson ED, Singer DE. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II. JAMA Cardiol. 2018 12 01; 3(12):1174-1182.
Score: 0.011
-
Inohara T, Kim S, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP. B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation. Heart. 2019 03; 105(5):370-377.
Score: 0.011
-
O'Brien EC, Holmes DN, Thomas LE, Fonarow GC, Allen LA, Gersh BJ, Kowey PR, Singer DE, Ezekowitz MD, Naccarelli GV, Ansell JE, Chan PS, Mahaffey KW, Go AS, Freeman JV, Reiffel JA, Peterson ED, Piccini JP, Hylek EM. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation. Circulation. 2018 08 28; 138(9):889-897.
Score: 0.011
-
Breathett K, Allen LA, Helmkamp L, Colborn K, Daugherty SL, Blair IV, Jones J, Khazanie P, Mazimba S, McEwen M, Stone J, Calhoun E, Sweitzer NK, Peterson PN. Temporal Trends in Contemporary Use of Ventricular Assist Devices by Race and Ethnicity. Circ Heart Fail. 2018 08; 11(8):e005008.
Score: 0.011
-
Durheim MT, Holmes DN, Blanco RG, Allen LA, Chan PS, Freeman JV, Fonarow GC, Go AS, Hylek EM, Mahaffey KW, Pokorney SD, Reiffel JA, Singer DE, Peterson ED, Piccini JP. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation. Heart. 2018 11; 104(22):1850-1858.
Score: 0.011
-
Breathett K, Liu WG, Allen LA, Daugherty SL, Blair IV, Jones J, Grunwald GK, Moss M, Kiser TH, Burnham E, Vandivier RW, Clark BJ, Lewis EF, Mazimba S, Battaglia C, Ho PM, Peterson PN. African Americans Are Less Likely to Receive Care by a Cardiologist During an?Intensive Care Unit Admission for Heart?Failure. JACC Heart Fail. 2018 05; 6(5):413-420.
Score: 0.011
-
Fudim M, Liu PR, Shrader P, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Hylek E, Go AS, Thomas L, Peterson ED, Piccini JP. Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry. J Am Heart Assoc. 2018 04 13; 7(8).
Score: 0.011
-
Bekelman DB, Allen LA, McBryde CF, Hattler B, Fairclough DL, Havranek EP, Turvey C, Meek PM. Effect of a Collaborative Care Intervention vs Usual Care on Health Status of Patients With Chronic Heart Failure: The CASA Randomized Clinical Trial. JAMA Intern Med. 2018 04 01; 178(4):511-519.
Score: 0.011
-
Chang LL, Xu H, DeVore AD, Matsouaka RA, Yancy CW, Fonarow GC, Allen LA, Hernandez AF. Timing of Postdischarge Follow-Up and Medication Adherence Among Patients With Heart Failure. J Am Heart Assoc. 2018 04 01; 7(7).
Score: 0.011
-
Steinberg BA, Shrader P, Pieper K, Thomas L, Allen LA, Ansell J, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli GV, Reiffel JA, Singer DE, Peterson ED, Piccini JP. Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II). J Am Heart Assoc. 2018 02 16; 7(4).
Score: 0.011
-
Inohara T, Shrader P, Pieper K, Blanco RG, Thomas L, Singer DE, Freeman JV, Allen LA, Fonarow GC, Gersh B, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Steinberg BA, Peterson ED, Piccini JP. Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study. JAMA Cardiol. 2018 01 01; 3(1):54-63.
Score: 0.011
-
Barnett AS, Kim S, Fonarow GC, Thomas LE, Reiffel JA, Allen LA, Freeman JV, Naccarelli G, Mahaffey KW, Go AS, Kowey PR, Ansell JE, Gersh BJ, Hylek EM, Peterson ED, Piccini JP. Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation). Circ Arrhythm Electrophysiol. 2017 Nov; 10(11).
Score: 0.010
-
Gurwitz JH, Magid DJ, Smith DH, Tabada GH, Sung SH, Allen LA, McManus DD, Goldberg RJ, Tisminetzky M, Go AS. Treatment Effectiveness in Heart Failure with Comorbidity: Lung Disease and Kidney Disease. J Am Geriatr Soc. 2017 Dec; 65(12):2610-2618.
Score: 0.010
-
Kaufman BG, Kim S, Pieper K, Allen LA, Gersh BJ, Naccarelli GV, Ezekowitz MD, Fonarow GC, Mahaffey KW, Singer DE, Chan PS, Freeman JV, Ansell J, Kowey PR, Rieffel JA, Piccini J, Peterson E, O'Brien EC. Disease understanding in patients newly diagnosed with atrial fibrillation. Heart. 2018 03; 104(6):494-501.
Score: 0.010
-
Nassif ME, Spertus JA, Jones PG, Fendler TJ, Allen LA, Grady KL, Arnold SV. Changes in disease-specific versus generic health status measures after left ventricular assist device implantation: Insights from INTERMACS. J Heart Lung Transplant. 2017 Nov; 36(11):1243-1249.
Score: 0.010
-
Hooker SA, Ross K, Masters KS, Park CL, Hale AE, Allen LA, Bekelman DB. Denver Spirited Heart: Mixed-Methods Pilot Study of a Psychospiritual Intervention for Heart Failure Patients. J Cardiovasc Nurs. 2017 May/Jun; 32(3):226-235.
Score: 0.010
-
Matlock DD, Jones J, Nowels CT, Jenkins A, Allen LA, Kutner JS. Evidence of Cognitive Bias in Decision Making Around Implantable-Cardioverter Defibrillators: A Qualitative Framework Analysis. J Card Fail. 2017 Nov; 23(11):794-799.
Score: 0.010
-
Cherian TS, Shrader P, Fonarow GC, Allen LA, Piccini JP, Peterson ED, Thomas L, Kowey PR, Gersh BJ, Mahaffey KW. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]). Am J Cardiol. 2017 06 01; 119(11):1763-1769.
Score: 0.010
-
Breathett K, Allen LA, Helmkamp L, Colborn K, Daugherty SL, Khazanie P, Lindrooth R, Peterson PN. The Affordable Care Act Medicaid Expansion Correlated With Increased Heart Transplant Listings in African-Americans But Not Hispanics or?Caucasians. JACC Heart Fail. 2017 02; 5(2):136-147.
Score: 0.010
-
Pandey A, Kim S, Moore C, Thomas L, Gersh B, Allen LA, Kowey PR, Mahaffey KW, Hylek E, Peterson ED, Piccini JP, Fonarow GC. Predictors and Prognostic Implications of?Incident Heart Failure in Patients With?Prevalent Atrial Fibrillation. JACC Heart Fail. 2017 01; 5(1):44-52.
Score: 0.010
-
Flint KM, Schmiege SJ, Allen LA, Fendler TJ, Rumsfeld J, Bekelman D. Health Status Trajectories Among Outpatients With Heart?Failure. J Pain Symptom Manage. 2017 02; 53(2):224-231.
Score: 0.010
-
Randolph TC, Simon DN, Thomas L, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Spertus JA, Peterson ED, Piccini JP. Patient factors associated with quality of life in atrial fibrillation. Am Heart J. 2016 Dec; 182:135-143.
Score: 0.010
-
Arnold SV, Jones PG, Allen LA, Cohen DJ, Fendler TJ, Holtz JE, Aggarwal S, Spertus JA. Frequency of Poor Outcome (Death or Poor Quality of Life) After Left Ventricular Assist Device for Destination Therapy: Results From the INTERMACS Registry. Circ Heart Fail. 2016 08; 9(8).
Score: 0.010
-
Magid M, McIlvennan CK, Jones J, Nowels CT, Allen LA, Thompson JS, Matlock D. Exploring cognitive bias in destination therapy left ventricular assist device decision making: A retrospective qualitative framework analysis. Am Heart J. 2016 10; 180:64-73.
Score: 0.010
-
Piccini JP, Simon DN, Steinberg BA, Thomas L, Allen LA, Fonarow GC, Gersh B, Hylek E, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Spertus JA, Peterson ED. Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry. JAMA Cardiol. 2016 06 01; 1(3):282-91.
Score: 0.010
-
Bui QM, Allen LA, Monte AA, Page RL, McIlvennan CK. Amphetamine-positive urine drug screens in the setting of mexiletine use: A case series. J Heart Lung Transplant. 2016 08; 35(8):1045-8.
Score: 0.009
-
Paine AM, Allen LA, Thompson JS, McIlvennan CK, Jenkins A, Hammes A, Kroehl M, Matlock DD. Anchoring in Destination-Therapy Left Ventricular Assist Device Decision Making: A Mechanical Turk Survey. J Card Fail. 2016 Nov; 22(11):908-912.
Score: 0.009
-
McIlvennan CK, Jones J, Allen LA, Swetz KM, Nowels C, Matlock DD. Bereaved Caregiver Perspectives on the End-of-Life Experience of Patients With a Left Ventricular Assist Device. JAMA Intern Med. 2016 Apr; 176(4):534-9.
Score: 0.009
-
Warraich HJ, Allen LA, Mukamal KJ, Ship A, Kociol RD. Accuracy of physician prognosis in heart failure and lung cancer: Comparison between physician estimates and model predicted survival. Palliat Med. 2016 07; 30(7):684-9.
Score: 0.009
-
Lum HD, Jones J, Lahoff D, Allen LA, Bekelman DB, Kutner JS, Matlock DD. Unique challenges of hospice for patients with heart failure: A qualitative study of hospice clinicians. Am Heart J. 2015 Sep; 170(3):524-30.e3.
Score: 0.009
-
Fendler TJ, Spertus JA, Gosch KL, Jones PG, Bruce JM, Nassif ME, Flint KM, Dunlay SM, Allen LA, Arnold SV. Incidence and predictors of cognitive decline in patients with left ventricular assist devices. Circ Cardiovasc Qual Outcomes. 2015 May; 8(3):285-91.
Score: 0.009
-
McIlvennan CK, Jones J, Allen LA, Lindenfeld J, Swetz KM, Nowels C, Matlock DD. Decision-making for destination therapy left ventricular assist devices: implications for caregivers. Circ Cardiovasc Qual Outcomes. 2015 Mar; 8(2):172-8.
Score: 0.009
-
Holmqvist F, Guan N, Zhu Z, Kowey PR, Allen LA, Fonarow GC, Hylek EM, Mahaffey KW, Freeman JV, Chang P, Holmes DN, Peterson ED, Piccini JP, Gersh BJ. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2015 May; 169(5):647-654.e2.
Score: 0.009
-
Gurwitz JH, Magid DJ, Smith DH, Hsu G, Sung SH, Allen LA, McManus DD, Goldberg RJ, Go AS. The complex relationship of race to outcomes in heart failure with preserved ejection fraction. Am J Med. 2015 Jun; 128(6):591-600.
Score: 0.009
-
O'Brien EC, Simon DN, Allen LA, Singer DE, Fonarow GC, Kowey PR, Thomas LE, Ezekowitz MD, Mahaffey KW, Chang P, Piccini JP, Peterson ED. Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014 Oct; 168(4):487-94.
Score: 0.008
-
Flint KM, Allen LA, Pham M, Heidenreich PA. B-type natriuretic peptide predicts 30-day readmission for heart failure but not readmission for other causes. J Am Heart Assoc. 2014 Jun 10; 3(3):e000806.
Score: 0.008
-
McIlvennan CK, Allen LA, Nowels C, Brieke A, Cleveland JC, Matlock DD. Decision making for destination therapy left ventricular assist devices: "there was no choice" versus "I thought about it an awful lot". Circ Cardiovasc Qual Outcomes. 2014 May; 7(3):374-80.
Score: 0.008
-
O'Brien EC, Holmes DN, Ansell JE, Allen LA, Hylek E, Kowey PR, Gersh BJ, Fonarow GC, Koller CR, Ezekowitz MD, Mahaffey KW, Chang P, Peterson ED, Piccini JP, Singer DE. Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J. 2014 Apr; 167(4):601-609.e1.
Score: 0.008
-
Afilalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA, Popma JJ, Ferrucci L, Forman DE. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014 Mar 04; 63(8):747-62.
Score: 0.008
-
Clarke CL, Grunwald GK, Allen LA, Bar?n AE, Peterson PN, Brand DW, Magid DJ, Masoudi FA. Natural history of left ventricular ejection fraction in patients with heart failure. Circ Cardiovasc Qual Outcomes. 2013 Nov; 6(6):680-6.
Score: 0.008
-
Peterson PN, Chan PS, Spertus JA, Tang F, Jones PG, Ezekowitz JA, Allen LA, Masoudi FA, Maddox TM. Practice-level variation in use of recommended medications among outpatients with heart failure: Insights from the NCDR PINNACLE program. Circ Heart Fail. 2013 Nov; 6(6):1132-8.
Score: 0.008
-
Hess PL, Kim S, Piccini JP, Allen LA, Ansell JE, Chang P, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Fonarow GC. Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation. Am J Med. 2013 Jul; 126(7):625-32.e1.
Score: 0.008
-
Smith DH, Thorp ML, Gurwitz JH, McManus DD, Goldberg RJ, Allen LA, Hsu G, Sung SH, Magid DJ, Go AS. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study. Circ Cardiovasc Qual Outcomes. 2013 May 01; 6(3):333-42.
Score: 0.008
-
Gurwitz JH, Magid DJ, Smith DH, Goldberg RJ, McManus DD, Allen LA, Saczynski JS, Thorp ML, Hsu G, Sung SH, Go AS. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med. 2013 May; 126(5):393-400.
Score: 0.008
-
Bowles EJ, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL, Habel LA, Yood MU, McCarty C, Magid DJ, Wagner EH. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012 Sep 05; 104(17):1293-305.
Score: 0.007
-
Bekelman DB, Nowels CT, Retrum JH, Allen LA, Shakar S, Hutt E, Heyborne T, Main DS, Kutner JS. Giving voice to patients' and family caregivers' needs in chronic heart failure: implications for palliative care programs. J Palliat Med. 2011 Dec; 14(12):1317-24.
Score: 0.007
-
Fitzgerald AA, Powers JD, Ho PM, Maddox TM, Peterson PN, Allen LA, Masoudi FA, Magid DJ, Havranek EP. Impact of medication nonadherence on hospitalizations and mortality in heart failure. J Card Fail. 2011 Aug; 17(8):664-9.
Score: 0.007
-
Peterson PN, Shetterly SM, Clarke CL, Bekelman DB, Chan PS, Allen LA, Matlock DD, Magid DJ, Masoudi FA. Health literacy and outcomes among patients with heart failure. JAMA. 2011 Apr 27; 305(16):1695-701.
Score: 0.007
-
Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC, Brieke A, Sauer WH. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. J Heart Lung Transplant. 2010 Jul; 29(7):771-6.
Score: 0.006
-
Dunlay SM, Gheorghiade M, Reid KJ, Allen LA, Chan PS, Hauptman PJ, Zannad F, Maggioni AP, Swedberg K, Konstam MA, Spertus JA. Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. Eur J Heart Fail. 2010 Apr; 12(4):367-74.
Score: 0.006
-
Ambardekar AV, Lowery CM, Allen LA, Cannon AP, Cleveland JC, Lindenfeld J, Brieke A, Sauer WH. Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads. J Card Fail. 2010 Apr; 16(4):327-31.
Score: 0.006
-
Liao L, Allen LA, Whellan DJ. Economic burden of heart failure in the elderly. Pharmacoeconomics. 2008; 26(6):447-62.
Score: 0.005
-
Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007 Jul 03; 50(1):40-7.
Score: 0.005
-
Lloyd-Jones DM, Camargo CA, Allen LA, Giugliano RP, O'Donnell CJ. Predictors of long-term mortality after hospitalization for primary unstable angina pectoris and non-ST-elevation myocardial infarction. Am J Cardiol. 2003 Nov 15; 92(10):1155-9.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|